Cimetidine-induced psychosis in a 14-year-old girl.

Por Papp, K A, Curtis, R M
Publicado em 1984

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

Por Ports, WC, Khan, S, Lan, S, Lamba, M, Bolduc, C, Bissonnette, R, Papp, K
Publicado em 2013

Phase I randomized study of KHK4083, an anti‐OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis

Por Papp, K.A., Gooderham, M.J., Girard, G., Raman, M., Strout, V.
Publicado no J Eur Acad Dermatol Venereol (2017)

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL stu...

Por Hong, C‐H., Papp, K.A., Lophaven, K.W., Skallerup, P., Philipp, S.
Publicado no J Eur Acad Dermatol Venereol (2017)

Management of egfr tki–induced dermatologic adverse events

Por Melosky, B., Leighl, N.B., Rothenstein, J., Sangha, R., Stewart, D., Papp, K.
Publicado no Curr Oncol (2015)

Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight

Por Hutmacher, MM, Papp, K, Krishnaswami, S, Ito, K, Tan, H, Wolk, R, Valdez, H, Mebus, C, Rottinghaus, ST, Gupta, P
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)

Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries

Por Buckley, R.F., Sparks, K.P., Papp, K.V., Dekhtyar, M., Martin, C., Burnham, S., Sperling, R.A., Rentz, D.M.
Publicado no J Prev Alzheimers Dis (2017)

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE

Por Papp, K.A., Barber, K., Bissonnette, R., Bourcier, M., Lynde, C.W., Poulin, Y., Shelton, J., Garces, K., Toole, J., Poulin‐Costello, M.
Publicado no J Eur Acad Dermatol Venereol (2015)

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Por Menter, A., Papp, K.A., Gooderham, M., Pariser, D.M., Augustin, M., Kerdel, F.A., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Chavers, S., Naessens, D., Sermon, J., Krueger, G.G.
Publicado no J Eur Acad Dermatol Venereol (2016)

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

Por Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Publicado no J Eur Acad Dermatol Venereol (2017)